Rethinking medtech in Covid times Whitepaper
COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made possible by radically interoperable data, artificial intelligence (AI), and transparent, secure platforms. In contrast to today, we expect treatment to be structured around the patient and not around the institutions that drive our current health care system. In 2020, there is an immediate need for preventive, diagnostic, and critical care on a large scale increased substantially compared to conventional seasonal demand forecasts.
The purpose of this whitepaper is to enlighten the importance and need of the Medical device market during the pandemic. Here, we highlight the evolution of Medtech companies during COVID-19, and what impact can be observed in their manufacturing, productions, demand and supply chain.
The whitepaper maps the journey by projecting its strengths and weaknesses and also bringing positive changes through its increased manufacturing and supplies. It will give a sneak-peek into the unprecedented demand for diagnostic tests, personal protective equipment PPE, ventilators and other essential medical supplies which is at the centre of attention of the MedTech industry due to the pandemic. The readers will also get a view of the current strategic developments, and market decisions being taken by the MedTech leaders of today